Lawyers for both sides in multidistrict litigation over the blood pressure medication Benicar have whittled a list of bellwether plaintiffs down to 10, but the first trial has been pushed back to 2017, lawyers in the case said.

The cases are being prepared for the first trial in federal court in Camden over alleged side effects of Benicar. U.S. District Judge Robert Kugler, who is presiding over the litigation, previously set a target date of late 2016 for the first trial, but the latest case management order shows depositions and pretrial motions running until at least March 31, 2017.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]